With the objective of determining the role of AMPs in ILD patients, we firstly compared the bronchoalveolar lavage (BAL) levels of AMPs in fibrotic (F-ILD) and non-fibrotic (NF-ILD) patients. The gene discussed is ADSL; the disease is interstitial lung disease.